Literature DB >> 10072757

Novel endothelin B receptor transcripts with the potential of generating a new receptor.

M Tsutsumi1, G Liang, P A Jones.   

Abstract

Using RT-PCR and rapid amplification of 5' cDNA ends (5' RACE), we have cloned three previously unrecognized endothelin B receptor (EDNRB) transcripts from a human melanoma cell line. Three distinct types of cDNAs (EDNRBDelta1, Delta2 and Delta3) were identified. EDNRBDelta1 starts upstream of the published transcription start site of hEDNRB without splicing, whereas, EDNRBDelta2 and EDNRBDelta3 are alternatively spliced. EDNRBDelta1 and EDNRBDelta2 share the same transcription initiation site and are 560bp upstream of the conventional hEDNRB, whereas that of EDNRBDelta3 is 939bp upstream from that described for the conventional hEDNRB. Interestingly, many transcription factor motifs are detectable in the upstream regions of these transcription initiation sites. The predicted amino acid sequences reveal that EDNRBDelta1 and EDNRBDelta2 produce the same protein as the conventional hEDNRB, but EDNRBDelta3 would give rise to additional in-frame 89- or 83-amino-acid residues at the N-terminus. EDNRBDelta3 generates the same amino acid sequence at the C terminus, but utilizes the polyadenylation signal within the open reading frame, resulting in a shorter 3'UTR. These transcripts are widely expressed in human tissues, but their expression patterns vary between different tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072757     DOI: 10.1016/s0378-1119(99)00014-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.

Authors:  Maria Vaiou; Evanthia Pangou; Panagiotis Liakos; Nikos Sakellaridis; George Vassilopoulos; Konstantinos Dimas; Christos Papandreou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-16       Impact factor: 4.553

Review 2.  Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

Authors:  Marc Q Mazzuca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

3.  Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor.

Authors:  Bertrand Allard; Anne Wijkhuisen; Aurélie Borrull; Frédérique Deshayes; Fabienne Priam; Patricia Lamourette; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

4.  Functional analysis of the endogenous retroviral promoter of the human endothelin B receptor gene.

Authors:  Josette-Renée Landry; Dixie L Mager
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Genetic Analyses of a Three Generation Family Segregating Hirschsprung Disease and Iris Heterochromia.

Authors:  Long Cui; Emily Hoi-Man Wong; Guo Cheng; Manoel Firmato de Almeida; Man-Ting So; Pak-Chung Sham; Stacey S Cherny; Paul Kwong-Hang Tam; Maria-Mercè Garcia-Barceló
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

6.  EDNRB isoform 3 confers Temozolomide resistance in A375 melanoma cells by modulating membrane potential, reactive oxygen species and mitochondrial Ca2.

Authors:  Yun Shan Chen; Fen Liu; Yi Hong Luo; Yue Fan; Fang Gui Xu; Pin Li; Bei Zhou; Xiu Yu Pan; Chi Chiu Wang; Long Cui
Journal:  Cancer Manag Res       Date:  2019-08-05       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.